Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1986-04-07
1988-08-02
Tanenholtz, Alvin E.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4351723, 435253, 435320, 935 10, 536 27, C12N 500, C12N 1500, C12N 120, C12N 100
Patent
active
047613750
ABSTRACT:
The mRNA of a distinct human Interleukin-2 concentrated from a plasma source lead to the production and cloning of its cDNA and the elucidation of its sequence and that of the mature protein. Transfer vectors for production of such Interleukin-2 are disclosed along with useful intermediate expression products.
REFERENCES:
patent: 4438032 (1984-03-01), Golde et al.
patent: 4530787 (1985-07-01), Shaked et al.
Taniguchi et al., Nature vol. 302, pp. 305-310, Mar. 24,1983.
Maeda et al., Biochem and Biophys Res. Commun., vol. 115, pp. 1040-1047, Sep. 30, 1983.
Devos et al., Nucleic Acid Res., vol. 11, pp. 4307-4323, Jul. 1983.
Bak Mary E.
Eisen Bruce M.
Genetics Institute Inc.
Kapinos Ellen J.
Tanenholtz Alvin E.
LandOfFree
Human interleukin-2 cDNA sequence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human interleukin-2 cDNA sequence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human interleukin-2 cDNA sequence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-711699